The Valley Desk

NCT03348631 · Interventional trial

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer

Overall registry status Active not recruiting

Phase 2

Conditions Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Malignant Uterine Corpus Neoplasm, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov